Form 4 for ATEX Anterix Inc.
Accepted 2022-05-19 00:00:00 ET · period of report 2022-05-17 · accession 0001209191-22-030497 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-19 | 2022-05-17 | ATEX | Ashe Gena L | CLO, Corp Sec | A - Grant | $0.00 | +9,112 | 42.8K | +27% | $0 |
| D | 2022-05-19 | 2022-05-17 | ATEX | Ashe Gena L | CLO, Corp Sec | A - Grant | $0.00 | +18.4K | 18.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-17 | A | A | 9,112 | $0.00 | 42,811 | D | — | — | (F1) Represents the issuance of restricted stock units (the "RSUs"). 25% of the RSUs vest and become exercisable on May 17, 2023, with the remaining RSUs vesting in 3 equal annual installments thereafter. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-05-17 | A | A | 18,368 | $0.00 | 18,368 | D | $49.39 · — to 2032-05-17 | 18,368 Common Stock | (F2) 25% of the option shares vest and become exercisable on May 17, 2023, with the remaining option shares vesting in 3 equal annual installments thereafter. |